Skip to content

OmniAb, Inc.

OABI OABIW

CIK 0001846253 · Services-Commercial Physical & Biological Research · Nasdaq, Nasdaq

  • Avista Public Acquisition Corp. II (until 2022-11-01)
← back to feed
Revenue (TTM)
$24.72M
−29.3% YoY Q1 Apr 2026
Net Income (TTM)
−$58.31M
−4.4% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.52
+6.6% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-246.9%
Q1 Apr 2026
Net Margin
-235.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$11.67M
Q1 Apr 2026
Cash
$29.05M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
144.97M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings